Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898432-08-000001
Filing Date
2008-01-03
Accepted
2008-01-03 20:11:33
Documents
1
Period of Report
2007-12-26

Document Format Files

Seq Description Document Type Size
1 ardeabioform4_ex.html 4  
1 ardeabioform4_ex.xml 4 6533
  Complete submission text file 0000898432-08-000001.txt   8622
Mailing Address 2131 PALOMAR ROAD SUITE 300 CARLSBAD CA 92011
Business Address 2131 PALOMAR ROAD SUITE 300 CARLSBAD CA 92011 760-602-8422
Ardea Biosciences, Inc./DE (Issuer) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL ST STE 2105 BATON ROUGE LA 70801
Business Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL STREET STE 2105 BATON ROUGE LA 70801 2253447780
ANDREEFF DANE (Reporting) CIK: 0001201810 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33734 | Film No.: 08509017